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Abstract
Adult stem cells are responsible for maintaining and repairing tissues during the life of an organism. Tissue repair in
humans, however, is limited compared to the regenerative capabilities of other vertebrates, such as the zebrafish (Danio
rerio). An understanding of stem cell mechanisms, such as how they are established, their self-renewal properties, and their
recruitment to produce new cells is therefore important for the application of regenerative medicine. We use larval
melanocyte regeneration following treatment with the melanocytotoxic drug MoTP to investigate these mechanisms in
Melanocyte Stem Cell (MSC) regulation. In this paper, we show that the receptor tyrosine kinase, erbb3b, is required for
establishing the adult MSC responsible for regenerating the larval melanocyte population. Both the erbb3b mutant and
wild-type fish treated with the ErbB inhibitor, AG1478, develop normal embryonic melanocytes but fail to regenerate
melanocytes after MoTP-induced melanocyte ablation. By administering AG1478 at different time points, we show that ErbB
signaling is only required for regeneration prior to MoTP treatment and before 48 hours of development, consistent with a
role in establishing MSCs. We then show that overexpression of kitla, the Kit ligand, in transgenic larvae leads to recruitment
of MSCs, resulting in overproliferation of melanocytes. Furthermore, kitla overexpression can rescue AG1478-blocked
regeneration, suggesting that ErbB signaling is required to promote the progression and specification of the MSC from a
pre–MSC state. This study provides evidence that ErbB signaling is required for the establishment of adult MSCs during
embryonic development. That this requirement is not shared with the embryonic melanocytes suggests that embryonic
melanocytes develop directly, without proceeding through the ErbB-dependent MSC. Moreover, the shared requirement of
larval melanocyte regeneration and metamorphic melanocytes that develops at the larval-to-adult transition suggests that
these post-embryonic melanocytes develop from the same adult MSC population. Lastly, that kitla overexpression can
recruit the MSC to develop excess melanocytes raises the possibility that Kit signaling may be involved in MSC recruitment
during regeneration.
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Introduction
As with other teleosts, the zebrafish has a remarkable ability to
regenerate a wide range of tissues and organs including fins [1],
heart [2], and retina [3–5]. Epimorphic regeneration, involving
the cell division and differentiation of undifferentiated post-
embryonic precursors, or adult stem cells, has been proposed for
each of these cases. Epimorphic regeneration requires several
distinct events for the function of the adult stem cell: establish-
ment, self-renewal, recruitment, and differentiation. In order to
understand regeneration and its practical application in medicine,
it is important to understand the molecular processes underlying
each of these events [6]. Very little is known about what
developmental mechanisms are required for establishing adult
stem cells. Furthermore, the relationship between adult stem cells
and the primary cells or tissue they regulate is not yet clearly
understood. It is unknown, for instance, whether adult stem cells
contribute to embryonic growth and then remain quiescent until
later recruitment, or if they are established by developmental
mechanisms that are distinct from embryonic precursors.
The zebrafish embryonic pigment pattern is an excellent genetic
model for investigating developmental processes [7]. Of the neural
crest derived pigmented cells, the melanocyte is of particular
interest as it is common to both zebrafish and human, and several
genetic pathways are conserved between the two [8–10]. The
embryonic melanocyte lineage arises from the neural crest
beginning at 14 hours post fertilization (hpf). The melanocyte
precursors, or melanoblasts, are not yet pigmented and migrate to
the periphery where they differentiate and begin to melanize by
24 hpf. Most of the embryonic population of melanocytes is
established by 3 dpf comprised of approximately 460 melanocytes
[10]. Except for approximately 20 additional melanocytes that
develop from 3–8 dpf at the horizontal myoseptum [11],
melanocyte number remains static, with little to no turnover,
PLoS Genetics | www.plosgenetics.org 1 July 2009 | Volume 5 | Issue 7 | e1000544until the adult pigment pattern is formed during metamorphosis at
,14 dpf [12].
We have developed a model for cell-specific regeneration of
melanocytes during the period of stasis between 3 and 14 dpf [13].
The melanocytotoxic chemical 4-(4-morpholinobutylthio)phenol
(MoTP) is converted into a cytotoxin by the melanin synthesis
enzyme tyrosinase. Accordingly, MoTP specifically ablates cells
that express tyrosinase at high levels, which in the embryo are
limited to melanoblasts and newly formed melanocytes. Typically
MoTP is applied for 2 days to completely ablate the embryonic
melanocyte lineage [13]. BrdU incorporation studies in regener-
ated melanocytes indicate that stem cells begin to divide to replace
dying melanocytes within 24 hours of MoTP exposure. Regener-
ation is complete within 3–4 days after MoTP washout, eventually
replacing melanocytes in all parts of the larvae except the ventral-
most yolk stripe. This procedure has allowed us to identify roles for
previously identified genes, such as the receptor tyrosine kinase kit
[13] in the development of melanocytes from the melanocyte stem
cell (MSC), as well as genes with regeneration-specific functions
that act at early and late stages of melanocyte regeneration [14]. kit
acts cell autonomously in the melanocyte lineage [10], responding
to its ligand (kitla in zebrafish) expressed in the skin or in cells
adjacent to the notochord [15] to promote migration [10,15,16],
survival [10,15,16], differentiation [17] and possibly cell division at
different stages of the melanocyte lineage. In mouse, in addition to
well described roles in the melanoblast and melanocyte, Kit is also
expressed in the MSC [18], although the role of its expression in
the MSC has not been explored. In zebrafish, roles for kit signaling
have been demonstrated for both larval [19] and adult [20]
melanocyte regeneration. It is not yet known whether this
requirement for kit is in the MSC itself, to promote recruitment
of these quiescent stem cells, or for subsequent differentiation of
regeneration melanoblasts, or both.
Genes identified by mutant phenotypes expressed during
metamorphosis of the embryonic or early larval pigment pattern
to the adult pigment pattern may also be involved in processes of
adult stem cell regulation [21–23]. Metamorphosis mutants puma
and picasso each show deficits in forming new melanocytes at the
onset of metamorphosis. The positional cloning of picasso revealed
that it was caused by a mutation in erbb3b, an epidermal growth
factor receptor (EGFR)-like tyrosine kinase. Furthermore, drug
inhibitors of the ErbB family of receptors, such as AG1478,
administered to WT larvae as early as 14–22 hpf phenocopied the
picasso metamorphic defect. This finding strongly suggested a role
for ErbB signaling during early embryonic development in
establishing the stem cells involved in adult melanocyte develop-
ment. An attractive possibility is that ErbB-dependent stem cells
responsible for metamorphosis are also responsible for surveilling
and regulating the larval melanocyte population.
In this study, we explore the role of ErbB signaling in
establishing MSC populations that are drawn on for larval
melanocyte regeneration. We show that both the picasso mutation
and the ErbB inhibitor, AG1478, abolish melanocyte regeneration
following embryonic melanocyte ablation by MoTP. Our results
indicate a requirement of ErbB activity concurrent with
embryonic melanocyte development and prior to melanocyte
ablation by MoTP, suggesting that ErbB signaling is required
during the establishment of larval MSCs. That both larval
regeneration and metamorphosis require early ErbB signaling
raises the possibility that the same stem cell population is involved
in both larval regeneration and metamorphosis.
Furthermore, the finding that picasso or ErbB inhibitor treated
embryos have normal embryonic pigment pattern but lack
functional stem cells involved in regeneration or metamorphosis
indicates there are two types of melanocytes: secondary larval
regeneration melanocytes that develop from an ErbB-dependent
stem cell, and primary ontogenetic, or embryonic, melanocytes
that develop independent of ErbB function.
We also examined how AG1478 affects the establishment of
MSCs. We took advantage of a transgenic line with constitutive
overexpression of the kit ligand a, Tg(cmv:kitla), which causes an
increase in the number of ontogenetic melanocytes. We investi-
gated which melanocyte lineage is responsible for increased
melanocytes by examining the effects of drugs that specifically
affect the stem-cell derived melanocytes. Thus, we show that the
drug ICI-118,551, which specifically blocks regeneration melano-
cyte development at the dct+ melanoblast stage but has no effect on
the development of embryonic or ontogenetic melanocytes, ablates
the kitla-mediated melanocyte increase in Tg(cmv:kitla) larvae.
Moreover, AG1478, that blocks the establishment of functional
MSCs, when given to Tg(cmv:kitla) larvae results in an additional
increase in ectopic melanocytes. This additional increase is also
blocked by the regeneration specific drug, ICI-118,551. That both
regeneration-specific drugs have an effect on the number of
ectopic melanocytes in Tg(cmv:kitla) larvae is evidence that
overexpression of kitla is acting through the MSC lineage to
produce excess melanocytes. That AG1478 does not reduce the
number of excess melanocytes in Tg(cmv:kitla) larvea suggests that
AG1478 arrests the stem cell lineage in a pre-stem cell stage (pre-
MSC) and that these pre-MSC cells can be activated by kitla
overexpression.
Results
ErbB Signaling Is Required for Larval Melanocyte
Regeneration, But Not Ontogeny
We were interested in testing whether ErbB signaling is required
for larval melanocyte regeneration and ontogeny. Thus, we treated
fish with the ErbB inhibitors AG1478 and PD158780 [24], or
DMSO, from 9–48 hpf, during neural crest and melanocyte
development. To assay for melanocyte regeneration, the fish were
also incubated with the melanocyte-specific cytotoxic drug, MoTP,
from 24–72 hpf (Figure 1A). Both ErbB inhibitors resulted in a
deficit in the number of regenerated melanocytes but not
Author Summary
The promise of regenerative medicine lies in the ability to
find or create stem cells that can be manipulated to
replace damaged tissues and organs. Such ability requires
an understanding of how adult stem cells are established
and then later recruited to regenerate different tissues.
Here, we study the zebrafish’s ability to regenerate
melanocytes, a pigment cell shared with humans, to
understand these mechanisms. We show that the erbb3b
gene is required to establish melanocyte stem cells in the
embryo that are responsible for regenerating melanocytes
after melanocytes are ablated in the larval zebrafish.
Because this adult stem cell is not required for the
development of embryonic melanocytes, we conclude that
adult melanocyte stem cells develop in parallel to the
embryonic tissues that they regulate. We also show that
overexpressing kit ligand a will result in over-recruiting
these adult stem cells to produce excess melanocytes.
Further exploration into the mechanisms by which the
zebrafish melanocyte stem cells are maintained and
recruited will inform how adult stem cells might be
manipulated for medical applications.
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129.1625.1 (mean6standard deviation) dorsal stripe melanocytes
by 7 dpf (Figure 1C), and following MoTP melanocyte ablation,
regenerate 91% (117.5624.0 melanocytes) of their ontogenetic
number (Figure 1D). Similarly, larvae treated with AG1478
(Figure 1E) have normal numbers (157.0621.2) of ontogenetic
melanocytes. However, when larvae are treated with both MoTP
and AG1478 (Figure 1F), they regenerate less than 8% (12.467.8
melanocytes) of their original ontogenetic number, and signifi-
cantly less than the number that regenerate following MoTP
treatment alone (P,0.0001). Larva treated with PD158780 and
MoTP showed a similar regeneration defect and were not
significantly different from AG1478 (P=0.5, not shown) and all
subsequent ErbB inhibitor experiments were conducted with
AG1478.
To test whether the gene erbb3b was specifically required for
regeneration, we treated erbb3b (picasso) mutants with DMSO or
MoTP from 24–72 hpf and assayed for melanocyte ontogeny and
regeneration at 7 dpf (Figure 1A). As was previously reported [23],
erbb3b mutants have no deficit in embryonic melanocyte ontogeny
(Figure 1G). erbb3b animals have 125.4613.7 dorsal and lateral
melanocytes in the trunk, which is not significantly different from
wild type (P=0.6). Following melanocyte ablation with MoTP,
erbb3b larvae also showed a defect in regeneration (Figure 1H),
regenerating approximately 33.2611.3 melanocytes, significantly
less than wild-type regeneration (P,0.0001).
Figure 1. ErbB signaling is required for larval melanocyte regeneration. (A) Cartoon of drug treatment timeline for assaying melanocyte
ontogeny and regeneration. Arrow indicates when embryos were collected for photos and melanocyte counts, in this case at 168 hpf. (B)
Quantitation of average dorsal melanocytes from somites 1–26 for each treatment in (A) for melanocyte ontogeny (gray) and melanocyte
regeneration (red). Error bars represent standard deviation, * represents P,0.05 (Student t-test, N=10). Photos of representative larvae at 168 hpf for
ontogeny (C, E, G) and regeneration (D, F, H). WT larvae regenerate nearly completely (compare D to C). WT treated with AG1478 (E, F) and erbb3b
mutants (G, H) largely fail to regenerate but have normal ontogenetic number of melanocytes. A few regeneration melanocytes are observed in the
head and sporadically in parts of the trunk (black bars in F and H) but are mostly absent throughout the trunk (red bars in F and H).
doi:10.1371/journal.pgen.1000544.g001
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regeneration was observed on the head and sporadically in parts
of the trunk (Figure 1F and 1H, black bars). The largest deficit in
regeneration was observed in the trunk in dorsal stripe (red bars)
and lateral stripe melanocytes. Curiously, the regeneration deficit
was more severe in inhibitor treated larvae than in erbb3b mutant
larvae. One possible explanation for this small increase in residual
number of regeneration melanocytes in the erbb3b mutants
(33.2611.3 melanocytes) compared to those that regenerate in
WT larvae (12.467.8 melanocytes) is that partial suppressors of
the regeneration defect have accumulated in the mutant stocks,
that act equally on the mutant and the pharmacological inhibitor.
Whatever is the cause of these increased residual melanocytes, the
finding that the deficit in regeneration is not increased by
combining the mutant and the pharmacological inhibitor
(42618.5 melanocytes, P=0.2) is consistent both with reports
that AG1478 is highly specific to the ErbB family of receptor
tyrosine kinases [25] and with several reports that AG1478 blocks
erbb2- and erbb3b-dependent signaling in zebrafish [23,24,26]. That
the inhibitor-treated mutants have no additional deficit in
regeneration melanocytes than either single perturbation argues
that any possible additional actions of the drug on other ErbB class
receptors or other kinases have no strong effects on the
establishment of the melanocyte stem cell.
ErbB Is Required for Larval Melanocyte Stem Cell (MSC)
Establishment, But Not in Recruitment or Differentiation
The early requirement for ErbB activity in promoting
metamorphosis suggested that it was required to establish a
population of precursors for adult melanocytes. To determine
whether ErbB signaling has a similarly early role in establishing
stem cells important for larval regeneration, we treated fish with
AG1478 at various time intervals both before and after MoTP
treatment and examined the number of dorsal trunk melanocytes
(somites 5–12) that regenerated (Figure 2A). We found that
incubations with AG1478 from 9–48 hpf and 24–72 hpf resulted
in reduced numbers of regenerated melanocytes (3.861.8 and
5.062.1 dorsal trunk melanocytes, respectively, Figure 2B)
compared to untreated controls (29.664.4 dorsal trunk melano-
cytes). In contrast, treatment with AG1478 after 48 hours resulted
in no significant effect on regeneration (35.3613.8 dorsal trunk
melanocytes, Figure 2B). These results suggest that AG1478 acts
prior to 48 hours to block melanocyte regeneration after the
MoTP-induced melanocyte ablation.
In the foregoing analysis, the ErbB inhibitor AG1478 was
applied in a series of applications overlapping with the embryo’s
exposure to the melanocyte ablation agent, MoTP. In those
experiments, melanocytes or melanoblasts likely begin to die early
in the MoTP treatment, between 24 and 48 hpf [27], thus
relieving their repressive effect on melanocyte stem cell recruit-
ment during the AG1478 treatment. It therefore remained
possible that the effect of AG1478 in these experiments was to
block recruitment of the MSC into developmental pathways
following MoTP-induced ablation, rather than preventing the
establishment of the MSC. To rule out this possibility, we delayed
application of MoTP until 48 hours, after AG1478 was washed
out. Like earlier MoTP exposure, melanoblasts and melanocytes
are ablated by exposure to MoTP between 48 and 96 hours.
Following washout of the MoTP, few new melanocytes regener-
ated (4.061.5 dorsal trunk melanocytes, Figure 2B). This result
argues that AG1478 is acting during stem cell establishment stage
to deplete the melanocyte stem cells and prior to any relief of
repression and subsequent recruitment that follows from the
delayed ablation of embryonic melanoblasts and melanocytes.
Although the above experiment positively demonstrates the
effect of AG1478 on blocking MSC establishment, it does not
exclude an additional effect of AG1478 on preventing recruitment
of the MSC following melanocyte ablation. To rule out such a
Figure 2. Regeneration requires ErbB signaling before 48 hpf. (A) Cartoon of drug treatment timeline. (B) Quantitation of average
regenerated dorsal trunk melanocytes from somites 5–12 for each treatment in (A) for untreated (gray) and AG1478 treated (blue). Error bars
represent standard deviation, * P,0.05, - P.0.05 (Student t-test, N=10). Time shifts with AG1478 treatment reveal that it blocks regeneration when
administered prior to 48 hpf. When AG1478 is added after 48 hpf regeneration is unaffected. The early effect is observed when MoTP treatment is
withheld until after AG1478 washout at 48 hpf.
doi:10.1371/journal.pgen.1000544.g002
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applied first, from 24–72 hpf, followed by AG1478 treatment from
72 to 144 hpf. In these larvae, melanocytes regenerated in
identical numbers to control larvae that were only treated with
MoTP (Figure 2B). This result indicates that AG1478 has no effect
on the recruitment of the melanocyte stem cell to re-enter
developmental pathways when the repressive effects of melano-
cytes and melanoblasts are relieved.
The preceding analyses, which show that AG1478 acts on the
MSC before embryonic melanocytes and melanoblasts are
ablated, argue that ErbB signaling acts to promote the
establishment of the melanocyte stem cell population rather than
on recruitment or differentiation of melanocytes from the stem cell
population during larval melanocyte regeneration. This conclusion
is consistent with previous studies that showed that AG1478
treatment during early embryonic stages was sufficient to block
melanocyte development during pigment pattern metamorphosis
nearly two weeks later [23]. Together, these studies provide
conclusive evidence that AG1478 blocks establishment during
embryonic stages of an adult stem cell, the MSC, that is
responsible for larval melanocyte regeneration and pigment
pattern metamorphosis.
Stem Cell Establishment Occurs in Anterior-to-Posterior
Progression
Because many aspects of zebrafish embryonic development and
neural crest development proceed in rostrocaudal progression
[7,28,29], we asked whether MSC establishment also proceeded
similarly. Accordingly, we incubated fish in AG1478 for shorter
times during the 9–48 hpf window that we showed was sufficient
for complete or nearly complete inhibition of dorsal melanocyte
regeneration (Figure 3A). Embryos exposed to AG1478 from 9–
30 hpf showed nearly complete inhibition of regeneration in dorsal
melanocytes in the trunk (9.168.0 melanocytes in somites 5–12),
but no deficit in the tail (20.764.6 melanocytes in somites 16–21).
In contrast, exposure to AG1478 from 30–48 hpf results in a
profound deficit in tail melanocyte regeneration (3.362.1
melanocytes in somites 16–21). This result suggests that MSCs
are established in a temporal rostral-caudal gradient similar to that
observed in zebrafish neural crest development [7,29].
ErbB Signaling Is Not Required for Stem Cell Self-Renewal
We were also interested in testing whether the ErbB inhibitor
AG1478 blocked the mechanism of stem cell self-renewal that we
postulate to occur during melanocyte regeneration. We have
shown that following multiple rounds of MoTP-induced melano-
cyte ablation [27], melanocytes continue to regenerate or undergo
pigment pattern metamorphosis. This property suggests that the
melanocyte stem cell that supports larval melanocyte regeneration
is not exhausted by making new melanocytes, but rather replaces
itself, or self-renews, each time it is recruited to divide and make
new melanocytes. We reasoned that these self-renewing divisions
may have properties similar to the mechanisms that establish the
stem cell during embryonic stages, and thus, might also require
Figure 3. Temporal shifts of AG1478 reveal stem cell establishment occurs in a rostrocaudal progression. (A) Cartoon of drug
treatment timeline. (B) Quantitation of average regenerated dorsal melanocytes for each treatment in (A) in the trunk (somites 5–12, in gray) and in
the tail (somites 16–21, in black). Error bars represent standard deviation, * P,0.05, - P.0.05 (Student t-test, N=10). Larvae not treated with AG1478
show full regeneration in the trunk and in the tail. When larvae are treated with the full AG1478 treatment, from 9–48 hpf, they fail to regenerate in
either the trunk or the tail. Larvae treated early with AG1478 from 9–30 hpf fail to regenerate in the trunk, but have normal regeneration in the tail.
Later treatments of AG1478 from 30–48 hpf show more regeneration in the trunk than in the tail. (C) Larva with early treatment of AG1478 from 14–
24 hpf showing a regeneration defect in the trunk but with normal regeneration in the head and tail.
doi:10.1371/journal.pgen.1000544.g003
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demonstrated for the in vitro self-renewal of human embryonic
stem cells [30]. Moreover, we reasoned that post-establishment
application of a drug that blocked self-renewal would allow for a
first round of melanocyte regeneration, but show deficits in
subsequent rounds of regeneration. Accordingly, we developed a
double regeneration assay (Figure 4A), by which melanocytes are
first simultaneously treated between 48 and 96 hpf with MoTP (to
ablate melanoblasts and melanocytes) and AG1478, to potentially
prevent self-renewal during this period. We had previously shown
that MSC division, and thus self-renewal, begins within 24 hours
of application of MoTP to the embryo [27], and also that AG1478
treatment at this stage has no effect on MSC recruitment or
differentiation (see above). The melanocytes and melanoblasts that
regenerate by 5 days are again ablated with a further 2 day
exposure to MoTP, and again allowed to regenerate. In these
experiments, we find that exposure to AG1478 during the first
round of MoTP treatment has no effect on the second round of
melanocyte regeneration (compare 44.0619.8 dorsal melanocytes
in AG1478-treated embryos to 42.6613.8 dorsal melanocytes in
MoTP-only-treated animals, P=0.9, Figure 4B). Thus, these
experiments suggest either that ErbB signaling is not required for
MSC self renewal, or, less likely, that a different population or
subset of MSC are deployed following each round of melanocyte
ablation and regeneration.
Overexpression of kit ligand a (kitla) Results in
Overproliferation of Ontogenetic Melanocytes
We were interested in the role of the kit receptor tyrosine kinase
in stem cell function. Previous work with conditional mutations in
kit have shown that, although kit activity is required for
regeneration, kit does not play an essential role in establishing
MSCs, but is required for early stages in the development of
melanocytes from stem cell precursors [13,31]. Additionally, we
previously reported that transiently overexpressing the kit ligand,
kitla in embryos results in 50% more melanocytes than wild type
[15]. We therefore wanted to investigate whether kitla overex-
pression might be recruiting the MSC to overproliferate or
generate excess melanocytes.
We asked whether kitla overexpression is acting on a transient
population of melanoblasts during the ontogenetic development of
melanocytes in the embryo. Wild-type animals develop nearly all
of their embryonic melanocytes by 3 dpf. These differentiated
melanocytes are post-mitotic, and there is little or no turnover of
melanocytes between 3 dpf and the onset of metamorphosis at
14 dpf [12]. Therefore, to rule out that kitla overexpression is
acting on a transient population of melanoblasts that are present
only from neural crest appearance at 14 hpf to, at the latest,
completion of embryonic melanocyte patterning at 72 hpf, we
induced kitla expression using the heat shock promoter
(pT2hsp70:kitla) in transiently injected embryos after 3 dpf. When
injected embryos are heatshocked at 4 and 5 dpf, we observed an
increase of 30% in the number of melanocytes by 8 dpf
(227.9618.3 dorsal melanocytes compared with 172.0613.7
dorsal melanocytes in WT, P,0.05, Figure 5). Injected but non-
heatshocked animals showed no significant increase in the number
of melanocytes (176.8618.3 dorsal melanocytes) compared with
uninjected animals (P=0.5, not shown). This result shows that the
precursors that give rise to excess melanocytes remain available to
kitla recruitment after embryonic melanocyte development is
completed at 72 hpf.
We next sought to determine whether kitla overexpression
caused an increase in melanocyte number by inducing cell
proliferation. We have previously shown that regenerated
Figure 4. ErbB signaling is not required for stem cell self-renewal. (A) Cartoon of drug treatment timeline for single and double regeneration
assays. (B) Quantitation of average regenerated dorsal melanocytes for each treatment in (A). Error bars represent standard deviation, - P.0.05
(Student’s t-test, N=10 for single regeneration, .5 for double regeneration). As previously shown (see Figure 2), when larvae are treated with
AG1478 after 2 dpf, they regenerate normally following a single round of MoTP treatment. When animals are treated with two rounds of MoTP (from
2–4 dpf and from 5–7 dpf) they regenerate slightly less melanocytes than a single round by 9 dpf. To test whether AG1478 treatment would block
stem cell self-renewal, we treated animals with MoTP and AG1478 from 2–4 dpf, and then with a second round of MoTP from 5–7 dpf. These animals
regenerated melanocytes similar to non-AG1478 treated larvae for double regeneration (P=0.9).
doi:10.1371/journal.pgen.1000544.g004
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indicating that MoTP-induced stem cell recruitment involves cell
division. Whereas MSC recruitment is thought to involve a step in
cell division, the excess cells following overexpression of kitla may
arise by an alternative mechanism not involving cell division, such
as the direct induction of latent melanoblast differentiation.
Therefore, we again injected the heatshock kitla overexpression
construct, pT2hsp70:kitla, into embryos and then treated the larvae
with BrdU for 4 days beginning at 4 dpf (Figure 5). We then
subjected pT2hsp70:kitla-injected and uninjected animals to
heatshock treatment at 4 and 5 dpf and assayed for BrdU-positive
melanocytes at 8 dpf (Figure 5A). In non-injected animals, 3 out of
81 (4%) melanocyte nuclei examined had BrdU staining. This low
fraction of BrdU-labeled cells was expected as the vast majority of
these melanocytes were born (and post-mitotic) before the BrdU
incubation. In larvae injected with pT2hsp70:kitla, however, 20 out
of 74 (27%) melanocyte nuclei examined had BrdU label. This
fraction is nearly identical to the fraction of excess cells we observe
for this heatshock treatment (,30%), indicating that cell division
accounts for all of the ectopic melanocytes observed in
pT2hsp70:kitla heatshocked embryos (Figure 3B). We conclude
that kitla overexpression causes an excess of melanocytes through a
mechanism that requires cell division.
To rule out the possibility that the above demonstrated cell
division events involve the cell division of differentiated melano-
cytes in response to overexpression of kitla, we asked whether
addition of the tyrosine kinase inhibitor, phenylthiourea (PTU),
after 3 dpf could inhibit the appearance of these excess
melanocytes. For this experiment we used a stable transgenic line
of fish that contain kitla under the control of the cmv promoter
(Tg(cmv:kitla)). Tg(cmv:kitla) animals have ubiquitous kitla mRNA
expression (not shown) and, similar to the previously reported
transient experiments, have ,50% more melanocytes than wild
type (see Figure 6 and Figure 7). In the presence of PTU,
melanocytes develop, but fail to form pigment. In these
experiments, we observed no increase in the number of pigmented
melanocytes in PTU-treated Tg(cmv:kilta) larva by 6 dpf (data not
shown), indicating that Tg(cmv:kitla)-induced melanocyte increase is
not a consequence of cell division of melanized melanocytes. We
therefore conclude that kitla recruits undifferentiated, or nonpig-
mented, cells to divide and differentiate into melanocytes. That
these cells can be recruited by overexpression of kitla at 4 or 5 dpf,
Figure 5. Overexpression of kitla after 4 dpf results in proliferation of melanocytes. (A) Cartoon of the pT2hsp70:kitla expression construct
used in heatshock experiments. The heatshock promoter, hsp70 drives kitla expression, allowing for expression of kitla after heatshocking the
injected embryos at 37uC. (B) Cartoon of experimental protocol. Following injection of pT2hsp70:kitla, larvae were heatshocked for 1 hour at 4 and
5 dpf in the presence of BrdU (from 4 to 8 dpf). (C) Quantitation of dorsal melanocytes represented as a percentage of wild type, and the percentage
of BrdU labeled melanocytes is represented in red for each treatment. Larvae injected with pT2hsp70:kitla and heatshocked develop approximately
30% more melanocytes than uninjected larva. These larvae also show an increased percentage of BrdU labeled melanocytes (,27%) that is
comparable to the number of excess melanocytes. Representative examples of melanocytes in WT (D, F, H) and pT2hsp70:kitla (E, G, I), showing
melanocyte nuclei stained with DAPI for WT (F) and pT2hsp70:kitla (G), and BrdU staining for WT (H) and pT2hsp70:kitla (I). Melanocytes considered
having BrdU+ nuclei are labeled with arrows and BrdU- nuclei are labeled with arrowheads.
doi:10.1371/journal.pgen.1000544.g005
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melanoblasts present, suggests that excess kitla is acting on an
earlier stage of melanocyte development. A candidate for a cell
capable of recruitment by kitla is the MSC.
ICI-118551 Prevents Differentiation of Melanocytes
During Regeneration, But Not Ontogeny
To establish that ectopic overexpression of kitla increases the
production of melanocytes through recruitment of the MSC
lineage, rather than the embryonic melanocyte lineage, we asked
whether this increase was sensitive to the MSC lineage-specific
drug, ICI-118,551. We identified ICI-118,551 in a screen for small
molecules that specifically blocked melanocyte regeneration
following MoTP induced ablation (A. Gottlieb and S. Johnson,
unpublished data). Ontogenetically developing embryonic mela-
nocytes develop normally, albeit with fainter pigment, in the
presence of ICI-118,551 (Figure 6C). In contrast, larvae
challenged to regenerate their melanocytes in the presence of
ICI-118,551 develop dct+ positive melanoblasts (Figure 6E), but
these melanocytes remain unmelanized (Figure 6D). This
difference in effect of ICI-118,551 in ontogenetic and regeneration
melanocytes is similar to the effect of the gfpt1 (eartha) mutation,
which also blocks melanocyte regeneration at the dct+ melanoblast
stage and has lighter pigmented ontogenetic melanocytes than WT
[14]. Thus, sensitivity of melanocytes to ICI-118,551 can be used
to distinguish whether melanocytes arise from the primary
embryonic melanocyte lineage or from the MSC lineage. ICI-
118,551 is a b2-adrenergic receptor antagonist in mammals and
fish, acting to block b2-adrenergic receptor-mediated cAMP
increase in fish larvae. This is easily observed by its effects on
contracting the melanosomes in the melanocyte. It is unlikely that
ICI-118,551’s effects on regeneration are mediated through b2-
adrenergic receptors, as other b2-adrenergic receptor antagonists,
which are effective in contracting melanosomes in fish, have no
effect on regeneration (not shown). Additionally, treating embryos
together with ICI-118,551 and Forskolin, which should result in
elevated cAMP levels and blocks the effect of ICI-118,551 on
melanocyte contraction, fails to block the effect of ICI-118,551 on
melanocyte regeneration. Thus, ICI-118,551 may be acting on a
yet identified pathway to specifically block zebrafish melanocyte
development from the melanocyte stem cell.
ICI-118,551 Suppresses kitla-Induced Overproliferation of
Melanocytes
To test whether kitla overexpression is recruiting melanocytes
from the stem cell lineage rather than from the ontogenetic
melanocyte lineage, we treated Tg(cmv:kitla) animals with ICI-
118,551 beginning at 9 hpf (Figure 6A) and asked whether the
drug could block differentiation of excess melanocytes. Indeed, the
number of melanocytes in ICI-118,551 treated Tg(cmv:kitla) larva
Figure 6. The regeneration specific drug, ICI-118,551, reveals that excess melanocytes in PT2hsp70:kitla larvae arise from the MSC
lineage. (A) Cartoon of drug treatment timeline. (B) Quantitative data for ontogeny and regeneration represented as percentage of WT melanocyte
numbers. Error bars show standard deviations, * P,0.05, - P.0.05 (Student’s t-test, N.7). (C) WT larvae treated with ICI-118,551 develop faintly
melanized ontogenetic melanocytes, in contrast to (D) failure to develop melanized melanocytes when challenged to regenerate in the presence of
ICI-118,551. (E) In situ analysis reveals regeneration proceeds to the dct+ melanoblast stage (arrows) in the presence of ICI-118,551. (F) ICI-118,551
treated PT2hsp70:kitla embryos develop similar numbers of faintly melanized melanocytes as ICI-118,551 treated embryos shown in (C). Differences in
iridophore appearance between (C) and (F) are results of slightly different illumination conditions.
doi:10.1371/journal.pgen.1000544.g006
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significantly different, from that of WT (191.4611.6, P=0.06).
This result indicates that the excess melanocytes in Tg(cmv:kitla)
animals develop from the stem cell lineage rather than from the
ontogenetic lineage.
AG1478 Enhances the Ectopic Melanocyte Phenotype of
kitla Overexpression
We were next interested in how AG1478 is acting to inhibit
MSC establishment. Specifically, we wanted to know whether
AG1478 killed the stem cell lineage, or whether it blocked the
MSC from developing from a pre-stem cell (pre-MSC) state. We
suspected that AG1478 prevented cells in the neural crest lineage
from achieving melanocyte stem cell specification, and that if these
precursors were still alive, they might be expressing kit [18], and
therefore might still be capable of recruitment through overex-
pression of kitla. To test whether kitla could induce AG1478-
treated larvae to produce excess melanocytes, we treated wild-type
and Tg(cmv:kitla) transgenic larvae with AG1478 from 9–30 hpf
(Figure 7B). This time period of AG1478 treatment prevented
melanocyte regeneration in the trunk but not the tail of larvae (see
Figure 3), providing an internal comparison between regions with
affected and less affected stem cells in the larvae. As noted earlier,
wild type larvae treated with AG1478 show no difference in the
number of melanocytes that develop in either the trunk or the tail
(Figure 7C). Untreated Tg(cmv:kitla) larva show an increase in the
number of melanocytes in both the trunk (64.869.4 dorsal
melanocytes, or 171% of wild type, Figure 7C) and the tail
(47.9612.2 dorsal melanocytes, or 168% of wild type, Figure 7C).
When Tg(cmv:kitla) larva are treated with AG1478, they show an
additional increase of 52% in the number of melanocytes in the
trunk (98.2618.6 dorsal melanocytes, Figure 7C) compared with
untreated Tg(cmv:kitla) (P,0.0001). In contrast to the two-
melanocyte width of the dorsal stripe typically observed in wt
larvae (Figure 7D), dorsal melanocyte stripes in Tg(cmv:kitla)
(Figure 7E), or AG1478 treated, Tg(cmv:kitla) (Figure 7F) larvae are
often four or six melanocytes wide, respectively. In these
experiments, this effect is much less pronounced in the tail of
AG1478-treated Tg(cmv:kitla) larvae (55.669.3 melanocytes,
Figure 7C). Compared with untreated Tg(cmv:kitla) (45.266.7
melanocytes, Figure 7C) this effect is less than a 20% increase
(P,0.05). That AG1478 enhances Tg(cmv:kitla)-induced overpro-
duction of melanocytes primarily in the trunk region where
AG1478 prevents the establishment of MSCs reinforces our
conclusions developed above that kitla overexpression is acting on
the MSC lineage, rather than embryonic melanoblasts and
melanocytes, to cause overproduction of melanocytes.
To rule out the possibility that kitla is recruiting cells from the
ontogenetic lineage when the MSCs are blocked with AG1478, we
treated Tg(cmv:kitla) larvae with both AG1478 and ICI-118,551
(See Figure 6A and 6B). When Tg(cmv:kitla) larva are treated with
AG1478 and ICI-118,551 together, we observed even fewer
ontogenetic melanocytes (44.6% of that of WT). This result
provides further evidence that kitla is capable of recruiting the
AG1478 pre-MSC. That fewer ICI-118,551-insensitive melano-
cytes develop in Tg(cmv:kitla) AG1478-treated larva might suggest
Figure 7. kitla melanocyte proliferation is enhanced by
AG1478. (A) Cartoon of the PT2hsp70:kitla construct in transgenic
animals. The constitutive cmv promoter drives expression of kitla. (B)
Schematic of drug treatment timeline with early treatment of AG1478.
(C) Quantitation of average ontogenetic dorsal melanocytes for each
treatment in (A) in the trunk (somites 5–12) and in the tail (somites 16–
21). Error bars represent standard deviation, * P,0.05, - P.0.05
(Student t-test, N=10). As reported previously (see Figure 1) WT larvae
show no effect in ontogenetic melanocyte number with AG1478
treatment compared to untreated WT. PT2hsp70:kitla animals have
significantly more melanocytes in both the trunk and the tail. Treating
PT2hsp70:kitla animals with AG1478 early, from 9–30 hpf, produces a
significantly greater number of melanocytes in the trunk. In contrast,
the tail region of AG1478-treated PT2hsp70:kitla larvae shows a
significant, but much smaller increase than the trunk, in the number
of excess melanocytes. (D) Trunk dorsal stripes of WT larvae are typically
two melanocytes wide. (E) PT2hsp70:kitla, however, have trunk dorsal
stripes that are about 4 cells wide. (F) AG1478-treated PT2hsp70:kitla
have trunk dorsal stripes ,6 melanocytes wide.
doi:10.1371/journal.pgen.1000544.g007
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suppressed when the stem cell lineage is overproliferating to such
an extent (230% of wild type).
Taken together, four lines of evidence converge to indicate that
the excess melanocytes that develop following overexpression of
kitla arise from the MSC lineage, rather than the ontogenetic
(ErbB-independent) lineage. These include (1) overexpression of
kitla is capable of inducing an excess of melanocytes after 4 dpf
when embryonic melanoblasts are not present; (2) all excess
melanocytes arise through cell division after kitla overexpression;
(3) ICI-118,551, which does not affect embryonic melanocyte
number, blocks the increase in kitla overexpressing animals and
lastly; (4) AG1478, acts specifically in the MSC lineage, modifies
the number of excess melanocytes in kitla overexpressing animals.
The foregoing analysis now allows us to draw two conclusions.
First, it suggests that AG1478 treatment does not kill the MSC, but
rather results in a cell that is now recruitable by excess kitla. This
cell does not have the full regulative abilities of a MSC, as
evidenced by the fact that it cannot respond to ablation of
embryonic melanocytes by making new melanocytes. Its presence,
rather than immediate death, is revealed by its responsiveness to
excess kitla. A parsimonious interpretation is that AG1478
prevents—and erbb3b is required for—the progression of a
precursor to the fully regulative MSC. The second conclusion is
that this precursor, that we refer to as a pre-MSC, is responsive to
kit signaling. Together with the findings that kitla overexpression
after 4 days induces overproduction of new melanocytes through
cell division of undifferentiated precursors (see Figure 5) from the
MSC lineage (see Figure 6) now provides functional evidence for a
role of kit signaling in both the pre-MSC and the MSC itself in
recruiting these cells to divide and produce more melanocytes.
Discussion
In this study, we have presented evidence for several conclusions
regarding the origin and recruitment of zebrafish adult melanocyte
stem cells (MSC). Our model for MSC establishment and
recruitment is presented in Figure 8, and has four salient features.
First, the establishment of the MSC requires ErbB activity to
progress from a pre-MSC to a MSC state. Second, the MSCs
responsible for regeneration in the larva may be identical to stem
cells previously shown to be involved in metamorphic patterning
of the adult fish [23]. Third, primary ontogenetic, or embryonic,
melanocytes develop independently of the MSC. Fourth, ectopic
overexpression of kitla can recruit both the MSC and the ErbB
inhibitor-arrested pre-MSC. The broader implications for these
findings are discussed in more depth below.
Role of ErbB Signaling in the Origin of the Adult
Melanocyte Stem Cell
We have both genetic and pharmacological evidence that ErbB
signaling is required for the establishment of the adult melanocyte
stem cell. Although we lack direct markers for the melanocyte stem
cell, we can draw strong inferences about its existence and
regulation from the ability of larvae to regenerate melanocytes,
the formation of new melanocytes upon pigment pattern
metamorphosis, or the regeneration of melanocyte stripes in the
regenerating adult fin. We have previously shown that following
ablation of embryonic melanocytes, cells with stem cell properties
are recruited to replace or regenerate the missing melanocytes [13].
This notion is supported by BrdU incorporation experiments that
showed that this cell and its daughters divide several times in
response to embryonic melanocyte ablation [13]. Here we show
Figure 8. Model for the parallel establishment of the zebrafish embryonic melanocyte lineage and the adult melanocyte stem cell
lineage. Our results indicate that there are two distinct melanocyte lineages that develop in the zebrafish embryo: the embryonic or ontogenetic
melanocyte lineage and the regenerative and metamorphic melanocyte lineage. In embryonic development, neural crest cells (squares) give rise to
dct+ melanoblasts (triangles), which later develop into embryonic melanocytes (black star). The regeneration and metamorphic lineage develops in
parallel to embryonic melanocytes, prior to 48 hpf and presumably from the neural crest. The establishment of melanocyte stem cells (MSCs, dark
circle) require ErbB signaling to progress from the pre-MSC state (light circle). The MSC can self-renew (circular arrow) and give rise to melanoblasts
and melanocytes during metamorphosis or regeneration, when inhibition from embryonic melanocytes (block arrow) is relieved. The MSC–derived
melanocytes are sensitive to developmental blockade by ICI-118,551 after the dct+ melanoblast stage. Ectopic expression of kitla can recruit the MSC
lineage by either inducing MSCs or pre–MSCs resulting in overproliferation of melanocytes.
doi:10.1371/journal.pgen.1000544.g008
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ation. We have mapped the timing of ErbB inhibitor action and
shown that ErbB signaling is required during periods of embryonic
development coincident with ontogenetic melanocyte migration
and differentiation (14–48 hpf). That ErbB inhibitors are blocking
the establishment of the MSC, rather than subsequent stages of
MSC recruitment, renewal, or differentiation, is demonstrated
positively by the fact that exposure of the larvae to the ErbB
inhibitor prior to MoTP-induced melanocyte ablation blocks
regeneration (Figure 2). That exposure to ErbB inhibitor during
or after MoTP treatment has no effect on subsequent melanocyte
regeneration suggests that ErbB signaling has no role in
recruitment, renewal, or differentiation of this lineage. Thus, we
conclude that the MSC is established during embryonic develop-
ment during stages of melanocyte migration from the neural crest,
and that establishment of the MSC requires ErbB signaling.
Regeneration and Metamorphosis Depend on a Shared
Melanocyte Stem Cell
Our finding that larval melanocyte regeneration was sensitive to
ErbB signal inhibition led us to explore whether the erbb3b mutant
was also defective for larval melanocyte regeneration following
ablation with MoTP. We find that embryos treated with ErbB
inhibitor and the erbb3b (picasso) mutant, which are both defective
for metamorphic melanocyte development [23], are also defective
for larval melanocyte regeneration. We also find that the ErbB
inhibitor acted to block regeneration early, from 9–48 hpf, which
is at a similar embryonic stage that it was found to prevent
melanocyte development during metamorphosis (12–22 hpf).
Together, these results suggest that both metamorphic melano-
cytes and regeneration melanocytes rely on the same ErbB-
dependent MSCs. The alternative possibility is that the zebrafish
has two distinct populations of MSCs established at similar times
with similar requirements for ErbB signaling. The development of
persistent labeling techniques for long-term clonal analysis will be
required to investigate the relationship between different melano-
cyte populations to more firmly rule out this latter possibility.
Our interpretation that larval regeneration melanocytes and
metamorphic melanocytes arise from the same adult stem cells sheds
some light on how adult stem cells may be regulated by different
mechanisms of repression or induction at different stages of
development. During larval stages (3–14 days), melanocyte develop-
ment is nearly static, with few or no new melanocytes developing
during this period (but see [11]). That ablation of embryonic
melanocytesduring thisstageactivatesthe MSCargues that the MSC
is repressed by differentiated embryonic melanocytes. Such repres-
sion might be direct interaction (as we propose in Figure 8) or
mediated by other cells, such as a yet unidentified MSC niche, that in
turn activates the MSC when the melanocyte is ablated. In contrast,
metamorphosis is a concerted set of developmental events initiated by
thyroid hormone [32] in the presence of embryonic melanocytes,
some of which can persist into the adult pattern [21]. This argues that
either the signals of metamorphosis override embryonic melanocyte
repression of the MSC, or that embryonic melanocytes no longer
repress the MSC during this developmental change. Thus, the
differences in mechanisms between MSC recruitment during
regeneration and metamorphosis will provide useful insights into
the regulation of adult stem cells.
Independent Lineage for Ontogenetic and Regenerative
Melanocytes
This study now provides strong evidence for two distinct
melanocyte lineages that populate the larval zebrafish. One
melanocyte population, which we have discussed extensively in
this study, is derived from an ErbB-dependent melanocyte stem
cell (bold circle in Figure 8), and develops in response to ablation
of earlier developing melanocytes. This earlier population, which
we refer to as embryonic or ontogenetic melanocytes, develops
directly from neural crest cells, and we argue does not develop
from an adult stem cell-like intermediate. It is difficult to formally
rule out such a stem cell precursor for the ontogenetic lineage, but
it is clear from the fact that their development is unperturbed in
mutants for erbb3b or following treatment with ErbB inhibitors that
the ErbB-dependent MSC is not a precursor for ontogenetic
melanocytes. Moreover, that the ErbB independent melanocyte
precursors in the ontogenetic lineage cannot regulate the larval
pigment pattern when the ErbB-dependent MSCs are blocked
suggests that a precursor for these cells do not persist in the larva
through self-renewal. Self-renewal, in contrast to depletion during
development, is a hallmark for embryonic or adult stem cells [33].
The two distinct mechanisms for development, direct and stem
cell-derived, have also been argued for the development of
melanocytes in the mouse. In this case, the differentiated
melanocytes of the first hair follicle are the result of direct
development, while the melanocytes of subsequent hair follicle
cycle are thought to derive from a MSC [18]. Thus, although the
biology of embryonic pigmentation and metamorphosis in
zebrafish superficially appears distinct from that of mammals,
these two results now suggest that the embryonic melanocytes in
zebrafish are analogous to those of the first hair follicle in mouse,
and post-embryonic melanocytes that appear during regeneration
or metamorphosis are analogous to the melanocytes of second and
subsequent hair follicles. Further investigation of each model
organism will determine the extent of the common requirements
and potential homologous mechanisms and will allow us to draw
stronger conclusions for understanding the origin of the MSC.
That both mammals and zebrafish appear to develop
melanocytes directly during embryogenesis and then subsequently
through adult stem cells raises the question of whether such modes
of development are a general theme in metazoan development.
Certainly in insects such as Drosophila, the embryo sets aside cells
that will develop via imaginal discs to then replace the larval
structure with the adult structures. The imaginal discs are not
themselves stem cells, and their development in the adult is largely
terminal. Yet in recent years, adult stem cells that provide for cell
turnover in the gut and other tissues have been described, raising
the possibility that the Drosophila embryo may also establish adult
stem cells [34–36]. Vertebrates seem to lack anything like the
imaginal discs of the fruit fly, and it may be that most post-
embryonic growth comes from adult stem cells. A parallel example
to what we describe here for embryonic (direct developing) and
stem cell-derived melanocytes may be provided by the develop-
ment of the blood. While the blood cells of the adult vertebrate,
referred to as definitive hematopoiesis, develop from a well
characterized adult stem cell called the hematopoietic stem cell
(HSC), primitive hematopoiesis, because of its transient nature,
has had no such self-renewing adult stem cell ascribed to it [37].
Clonal analysis in Xenopus with these two populations of blood
origin indicates that the primitive and definitive blood are derived
from independent lineages [38]. Similar clonal analysis will be
required to further examine the relationship between the
melanocyte stem cell we have described here and the embryonic
melanocyte lineage. Exploration of other types of adult stem cells
and their corresponding embryonic tissues will reveal whether
parallel development of the embryo and the establishment of the
adult stem cell from distinct lineages is a general theme in
vertebrate development.
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Fish Rearing and Stocks
Adult fish were maintained at 25–27uC, 14L:10D standard
treatment (Westerfield, http://zfin.org/zf_info/zfbook/zfbk.html).
Embryos and larval fish were reared at 28uC in 2 ppt marine salt
(Coral Life, Carson, CA) in carbon-filtered tap water. Larvae were
fed rotifers after 5 dpf. Wild type embryos photographed were sjA
(http://zfin.org). All quantitative analysis for wild-type fish was
conducted with fish mutant for melanophilin (mlpha), which
contracts melanosomes within the melanocyte but does not effect
the number or pattern of melanocytes [39]. The erbb3b (picasso)
mutant, which has normal number of embryonic melanocytes but
fails to develop normal adult melanocyte patterning, was
previously described [23].
Pharmacological Inhibitors
The kinase inhibitors AG1478 (Calbiochem) and PD158780
(Calbiochem) were dissolved in dimethyl sulphoxide (DMSO) to
make a stock solution (6 mM AG1478 and 600 mM PD158780)
and stored at 220uC in a light protected vessel. Dose response
testing (1, 3, 5, and 10 mM) revealed a strong effect with limited
lethality at 3 mM for both drugs. Unless otherwise noted, embryos
were incubated in Petri dishes with 3 mM AG1478 with 0.5%
DMSO in 2 ppt marine salt water, with one embryo per ml.
Embryos were kept in the dark during incubation to protect drugs
from light degradation.
The regeneration blocker ICI-118,551 was identified in a small
molecule screen for drugs that specifically inhibit larval regener-
ation. Embryos were placed in MoTP (50 mM) and each of the
1250 drugs (10 mM) in the LOPAC (Library of Pharmacologically
Active Compounds, Sigma, St. Louis, MO) panel at 12 hpf in 96
well plates. MoTP was washed out of each well at 3 dpf and
replaced with additional drug. Drugs that inhibited regeneration
by 6 dpf were tested for their effects on ontogenetic melanocyte
development. Embryos treated with 30 mM ICI-118,551, had a
complete absence of regenerated melanocytes but displayed a
normal number of ontogenetic melanocytes.
MoTP-Induced Melanocyte Ablation
MoTP (4-(4-morpholinobutylthio)phenol) stock solution
(50 mM) was made up in DMSO, and stored at room temperature
in a light protected vessel. Embryos were incubated in 50 mM
MoTP in 2 ppt water for 48 hour incubation periods and assayed
for regeneration after at least an additional 48 hours post washout.
Embryos were visually inspected for complete melanocyte death
24 hours after washout.
Melanocyte Counts
To assay for either melanocyte ontogeny or regeneration
quantitatively, we counted dorsal melanocytes. Unless otherwise
noted, these include melanocytes along the dorsum of the larva
from somites 1–26. In each Figure we present the mean number of
dorsal melanocytes with error bars indicating standard deviation.
P-values for statistical significance were obtained by using
Student’s t-test in Microsoft Excel.
kitla Overexpression
Fish transgenic for an overexpression line of the kit ligand a (kitla)
driven under the cmv promoter, Tg(cmv:kitla)
j901, were created. The
cmv:kitla construct previously described [15] was cloned into the
tol2 transposable element using the pT2KXIG vector [40] at the
XhoI and BglI sites (pT2cmv:kitla). Capped transposase RNA was
synthesized from pCS-TP, provided by K. Kawakami, using the
mMessage mMachine SP6 RNA synthesis kit (Ambion, Austin
TX). A transposase injection solution was prepared fresh each day
of injecting composed of 25 mg/ml pT2cmv:kitla DNA, 25 mg/ml
transposase mRNA, and 0.1% phenol red (Sigma, St Louis MO)
in 16 Danieau buffer. Animals were injected with 1–2 nl of
pT2cmv:kitla transposase injection solution at the 1 or 2 cell stage.
The mosaic F0 animals were scored for kitla induced hyperpig-
mentation at 5 dpf and bred to sjA to test for germ line
transmission. A single F1 male was selected that had robust
hyperpigmentation phenotype in 50% of its offspring when crossed
with sjA. Expression of kitla was examined with RNA in situ
hybridization in these siblings. All embryos with kitla phenotype
stained positive for ubiquitous kitla mRNA expression, whereas
only ,5% of animals scored as WT stained for ubiquitous kitla
mRNA. Experiments presented here are with Tg(cmv:kitla)
j901/+ F4
embryos.
For heat inducible kitla overexpression, kitla was placed under
the control of the heatshock promoter, hsp70 [41], and cloned into
the tol2 vector, pT2ef1:GFP. This construct has a lineage tracing
GFP marker under constitutive expression by the Xenopus
elongation factor 1 alpha promoter. Animals were injected with
between 1–2 nl of 25 mg/ml pT2hsp70:kitla and 25 mg/ml
transposase RNA at the 1 or 2 cell stage. Genomic integration
of the pT2hsp70:kitla construct was determined by GFP expression
at 24 hpf, typically observed in .95% of injected animals. Only
GFP+ embryos were used in heatshock experiments. Heatshock
activation of kitla expression was performed by placing embryos in
50 ml conical tubes with 25 ml embryo medium and placing the
tubes in a 37uC water bath for 30 minutes. All of the pT2hsp70:kitla
construct experiments presented here are using F0 mosaic
embryos.
BrdU Labeling
Cell division events in the melanocyte lineage were detected by
retention of 5-bromo-29-deoxyuridine (BrdU). Animals mosaic for
pT2hsp70:kitla genomic integration were immersed in BrdU (5 mM)
for 96 hours beginning at 4 dpf. To induce kitla expression, animals
were heatshocked at 4 and 5 dpf. Animals were then harvested at
8 dpf and fixed with 4% paraformaldehyde in phosphate buffered
saline buffer (pH 7). More than 20 animals for each treatment were
embedded inparaffinwaxandsectionedinto5-micron-thicksagittal
sections. Sections were deparaffinized and incubated with mouse
anti-BrdU monoclonalantibody(1:300dilution,RocheDiagnostics,
Indianapolis, IN), followed by a secondary incubation with Alexa
Fluor 594-conjugated goat anti-mouse Ig (1:300 dilution, Invitro-
gen), and 49,6-diamidino-2-phenylindole (DAPI, 100 ng/ml; Sig-
ma, St. Louis, MO) for nuclear staining [13]. BrdU incorporation
was determined by first identifying DAPI-positive nuclei (blue
fluorescence) in pigmented melanocytes, then assessing BrdU
incorporation (red fluorescence)in each identifiednucleus. Example
nuclei that were categorized as BrdU negative (arrowheads) and
BrdU positive (arrows) are shown in Figure 5C–5H.
RNA In Situ Hybridization
RNA in situ analysis was used to asses the presence of dct-
expressing melanoblasts. Larvae were fixed in 4% paraformalde-
hyde in phosphate buffered saline (pH 7) at 5 dpf. cDNA for dct
was amplified using PCR primers 59-TACCTGTCGGAGGCT-
CAGTT-39 and (with T7 sequence in lowercase) 59-taatacgact-
cactatagggTACGCTGGTCACAGTTCAGC-39 from first strand
cDNA of 48 hpf embryos. Digoxygenin (DIG) labeled RNA
probes from dct cDNA template were made using T7 RNA
polymerase using the protocol at http://zfish.wustl.edu. Anti-DIG
in situ hybridization was performed as previously described [42].
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